Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Mole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableActive Not RecruitingNCT04562558
What this trial is testing

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Who this might be right for
Gestational Trophoblastic TumorGestational Trophoblastic NeoplasiaStage I Gestational Trophoblastic Tumor+4 more
xiang yang 228
Not applicableStudy completedNCT04406454
What this trial is testing

The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

Who this might be right for
Healthy SkinNevus
Taipei Veterans General Hospital, Taiwan 60
Not applicableStudy completedNCT04550000
What this trial is testing

Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits

Who this might be right for
Melanoma (Skin)Pigmented SkinNevus
DermTech 652
Not applicableStudy completedNCT01500304
What this trial is testing

Minimally Invasive Groin Dissection for Melanoma

Who this might be right for
Melanoma
Mayo Clinic 88
Not applicableStudy completedNCT01556503
What this trial is testing

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Who this might be right for
Melanoma
OHSU Knight Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Early research (Phase 1)Ended earlyNCT06448364
What this trial is testing

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+2 more
Pfizer 4
Not applicableLooking for participantsNCT05059444
What this trial is testing

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Who this might be right for
Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+14 more
Guardant Health, Inc. 2,285
Not applicableLooking for participantsNCT07469709
What this trial is testing

Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

Who this might be right for
Breast CancerColo-rectal CancerOvarian Cancer+2 more
Fondazione del Piemonte per l'Oncologia 850
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00275496
What this trial is testing

Multicenter Selective Lymphadenectomy Trial (MSLT)

Who this might be right for
Melanoma
Saint John's Cancer Institute 2,001
Testing effectiveness (Phase 2)Ended earlyNCT05012397
What this trial is testing

Milademetan in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more
Rain Oncology Inc 40
Not applicableStudy completedNCT04146064
What this trial is testing

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Who this might be right for
NSCLCMelanomaKidney Cancer+2 more
University Health Network, Toronto 190
Not applicableStudy completedNCT03638492
What this trial is testing

Trial of Surgical Excision Margins in Thick Primary Melanoma - 2

Who this might be right for
MelanomaSurgeryTreatment Outcome
Peter Gillgren 936
Not applicableUnknownNCT04353050
What this trial is testing

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Who this might be right for
MelanomaMelanoma (Skin)Moles+9 more
Russian Academy of Medical Sciences 350
Not applicableUnknownNCT05223218
What this trial is testing

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+2 more
Namida Lab 500
Not applicableLooking for participantsNCT06605443
What this trial is testing

Precision Medicine for L/GCMN and Melanoma 2

Who this might be right for
Melanoma (Skin Cancer)Nevi and MelanomasCongenital Melanocytic Nevus
Fundacion Clinic per a la Recerca Biomédica 100